The abstract is read at the publisher; the summary is JClub's.
HLA-DP variants in healthy individuals show opposing links to CMV immunity, with SG1 (low expression, predicted peptide presentation, NKp44 binding) tied to weaker CD4+ T cell responses and higher seropositivity.
- Why it matters: HLA class II DP genetic variability’s impact on CMV immunity is unclear, limiting understanding of how innate and adaptive responses are shaped by DP function.
- What they did: The study predicted CMV-encoded peptide binding across frequent HLA-DP molecules, then measured DP-restricted CD4+ T cell responses and CMV serostatus, correlating results with DP variants grouped into four functional supergroups.
- The result: DP variants in SG1 were associated with weaker anti-CMV CD4+ T cell responses versus variants with opposite features, and SG1 homozygosity increased the likelihood of CMV seropositivity in hematopoietic stem cell donors.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.